Concepedia

C. DUFRESNE

CD

Statistics

Publications

11

Citations

803

H-Index

10

Active since

1987

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Merck Canada Inc. (Canada)

C. DUFRESNE is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, medicinal chemistry, and pharmacy.

Publications per year

1987–2006

11

Publications

11

Zaragozic acids: a family of fungal metabolites that are picomolar competitive inhibitors of squalene synthase.

James D. Bergstrom, Marc M. Kurtz, Deborah J. Rew et al. · Proceedings of the National Academy of Sciences · 1993 · 335 citations

, , +12

Activation of the human peripheral cannabinoid receptor results in inhibition of adenylyl cyclase.

Deborah Slipetz, Gary P. O’Neill, Leonard Favreau et al. · Molecular Pharmacology · 1995 · 194 citations

, , +17

Metabolic profiles of montelukast sodium (Singulair), a potent cysteinyl leukotriene1 receptor antagonist, in human plasma and bile.

Suresh K. Balani, Xin Xu, Vijaya S. Pratha et al. · PubMed · 1997 · 94 citations

, , +12

Novel cyclization of S-(o-acetylaryl) dimethylthiocarbamates. A new synthesis of 3-hydroxybenzothiophenes and 2-hydroxythiochromones

C.‐K. LAU, Patrice C. Bélanger, C. DUFRESNE et al. · The Journal of Organic Chemistry · 1987 · 36 citations

, , +6

Evolution of a series of non-quinoline leukotriene D4 receptor antagonist; synthesis and sar of benzothiazoles and thiazoles substituted benzyl alcohols as potent LTD4 antagonists

Cheuk K. Lau, C. DUFRESNE, Yves Gareau et al. · Bioorganic & Medicinal Chemistry Letters · 1995 · 31 citations

, , +14

1–5 of 11